• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical and bone marrow effects of interferon alfa therapy in myelofibrosis with myeloid metaplasia.

作者信息

Tefferi A, Elliot M A, Yoon S Y, Li C Y, Mesa R A, Call T G, Dispenzieri A

出版信息

Blood. 2001 Mar 15;97(6):1896. doi: 10.1182/blood.v97.6.1896.

DOI:10.1182/blood.v97.6.1896
PMID:11263440
Abstract
摘要

相似文献

1
Clinical and bone marrow effects of interferon alfa therapy in myelofibrosis with myeloid metaplasia.
Blood. 2001 Mar 15;97(6):1896. doi: 10.1182/blood.v97.6.1896.
2
alpha-Interferon in myelofibrosis: a case report.α-干扰素治疗骨髓纤维化：一例报告
Br J Haematol. 1994 Mar;86(3):654-6. doi: 10.1111/j.1365-2141.1994.tb04802.x.
3
[Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].[接受α-干扰素治疗的慢性髓性白血病患者中的骨髓纤维化]
Arkh Patol. 2003 Jul-Aug;65(4):9-12.
4
Alpha interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasia.α干扰素治疗有症状的髓样化生骨髓纤维化
Eur J Haematol. 1987 Sep;39(3):228-32. doi: 10.1111/j.1600-0609.1987.tb00762.x.
5
Thalidomide: no benefit in myelofibrosis with myeloid metaplasia.沙利度胺：对伴有髓外化生的骨髓纤维化无益处。
Lancet Oncol. 2003 Feb;4(2):70. doi: 10.1016/s1470-2045(03)00999-9.
6
Reversible bone marrow aplasia induced by pegylated interferon-α-2a therapy in a patient with primary myelofibrosis.聚乙二醇化干扰素-α-2a治疗原发性骨髓纤维化患者引起的可逆性骨髓再生障碍。
J Oncol Pharm Pract. 2014 Oct;20(5):386-92. doi: 10.1177/1078155213504444. Epub 2013 Sep 24.
7
Reversal of myelofibrosis by hydroxyurea.
Eur J Haematol. 1990 Jan;44(1):33-8. doi: 10.1111/j.1600-0609.1990.tb00344.x.
8
A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia.
Br J Haematol. 2001 Jul;114(1):111-3. doi: 10.1046/j.1365-2141.2001.02883.x.
9
Red cell aplasia in myelofibrosis with myeloid metaplasia. A distinct functional and clinical entity.骨髓纤维化伴髓外化生中的红细胞再生障碍。一种独特的功能和临床实体。
Cancer. 1983 Oct 1;52(7):1290-6. doi: 10.1002/1097-0142(19831001)52:7<1290::aid-cncr2820520726>3.0.co;2-8.
10
Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia.
Blood. 2002 Mar 15;99(6):2255-8. doi: 10.1182/blood.v99.6.2255.

引用本文的文献

1
Modern management of splenomegaly in patients with myelofibrosis.骨髓纤维化患者脾肿大的现代治疗方法。
Ann Hematol. 2020 Jul;99(7):1441-1451. doi: 10.1007/s00277-020-04069-4. Epub 2020 May 17.
2
Guideline on myeloproliferative neoplasms: Associacão Brasileira de Hematologia, Hemoterapia e Terapia Cellular: Project guidelines: Associação Médica Brasileira - 2019.骨髓增殖性肿瘤指南：巴西血液学、血液治疗与细胞治疗协会：项目指南：巴西医学协会 - 2019年
Hematol Transfus Cell Ther. 2019 Jul;41 Suppl 1(Suppl 1):1-73. doi: 10.1016/j.htct.2019.03.001. Epub 2019 May 10.
3
A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms.
一项芦可替尼联合阿扎胞苷治疗骨髓增生异常综合征/骨髓增殖性肿瘤的 II 期临床试验。
Am J Hematol. 2018 Feb;93(2):277-285. doi: 10.1002/ajh.24972. Epub 2017 Nov 27.
4
Myelofibrosis: an update on drug therapy in 2016.骨髓纤维化：2016年药物治疗最新进展
Expert Opin Pharmacother. 2016 Dec;17(18):2375-2389. doi: 10.1080/14656566.2016.1252333. Epub 2016 Nov 7.
5
Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes.骨髓纤维化和骨髓增生异常/骨髓增殖性重叠综合征的治疗方法。
Onco Targets Ther. 2016 Apr 15;9:2273-86. doi: 10.2147/OTT.S83868. eCollection 2016.
6
Profile of pomalidomide and its potential in the treatment of myelofibrosis.泊马度胺概况及其在骨髓纤维化治疗中的潜力。
Ther Clin Risk Manag. 2015 Apr 2;11:549-56. doi: 10.2147/TCRM.S69211. eCollection 2015.
7
Management of thrombocythemia.血小板增多症的管理。
F1000Res. 2014 Sep 29;3:227. doi: 10.12688/f1000research.5361.1. eCollection 2014.
8
Conventional and experimental drug therapy in myelofibrosis with myeloid metaplasia.骨髓纤维化伴髓样化生的常规和实验药物治疗。
Curr Hematol Malig Rep. 2007 Feb;2(1):25-33. doi: 10.1007/s11899-007-0004-4.
9
The prediction of interferon treatment effects based on time series microarray gene expression profiles.基于时间序列微阵列基因表达谱预测干扰素治疗效果。
J Transl Med. 2008 Aug 9;6:44. doi: 10.1186/1479-5876-6-44.
10
The therapy of myelofibrosis: targeting pathogenesis.骨髓纤维化的治疗：针对发病机制
Int J Hematol. 2002 Aug;76 Suppl 2:296-304. doi: 10.1007/BF03165138.